Log in  First Connection?

Preventive Cardiology & Cardiovascular Risk Factors: Archives News of the month

Handgrip strength and menopause are associated with cardiovascular risk in women with obesity: a cross-sectional study

 Published on 07/04/2025 |  Original article (Abstract)  | Freitas Jaqueline de Paula Chaves et al. | BMC Women's Health 2025; 25(1): 155

Cardiovascular disease (CVD) is among the leading causes of death and disability worldwide [1] e. Cardiovascular risk (CVR) is the probability of an individual developing cardiovascular disease or experiencing cardiovascular events during a specific period [2]. Obesity is classified when the body mass...

Familial hypercholesterolemia in patients with hypertension: the China H-type Hypertension Registry Study

 Published on 31/03/2025 |  Original article (Abstract)  | Shen Tianzhou et al. | Lipids in Health and Disease 2025; 24(1): 116

Familial hypercholesterolemia (FH) is an inherited cholesterol metabolism disorder characterized primarily by extremely high levels of low-density lipoprotein cholesterol (LDL-C) and an increased risk of accelerated atherosclerosis and premature coronary heart disease (CHD) [1, 2–3]. The prevalence...

Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

 Published on 24/03/2025 |  Original article (Abstract)  | Di Giacomo Barbagallo Francesco et al. | Cardiovascular Diabetology 2025; 24(1): 126

Familial hypercholesterolemia (FH) is the most common monogenic lipid disorder characterized by lifelong exposure to high levels of low-density lipoprotein cholesterol (LDL-C) and by an increased risk of premature atherosclerotic cardiovascular disease (ASCVD) [1]. In FH subjects different mutations...

Reduction of cardiovascular risk factors by the diet – Evaluation of the MoKaRi concept by a parallel-designed randomized study

 Published on 17/03/2025 |  Original article (Abstract)  | Dawczynski Christine et al. | Lipids in Health and Disease 2025; 24(1): 88

Cardiovascular diseases (CVD) are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths [1, 2]. In 2021, the prevalence rate of CVD in Germany was 22.1% in people over 65 years of age. The highest rates of CVD were observed...

PCSK9 Inhibitors: The Evolving Future

 Published on 10/03/2025 |  Original article (Abstract)  | Bijay Mukesh Jeswani et al. | Health Science Reports 2024; 7(11): 70174

The history of PCSK9 inhibition begins with pioneering genetic discoveries that clarified PCSK9's function in controlling LDL cholesterol (LDL‐C) levels and its effects on cardiovascular health [1]. In the absence of a mutation in the gene encoding LDL receptor or apolipoprotein B (APOB), certain...